62 - Pharmacotherapy of anxiety Flashcards
drugs that can cause anxiety
albuterol
antipsychotics
bupropion
caffeine
decongestants.
cocaine, meth
levothyroxine
steroids
stiulants
theophylline
Buspirone
buspirone is a ___ receptor agonist
approved for ___
often not dosed appropriately for efficacy
- target of ___ - ___ mg ___ time daily (30-45 mg/day)
may take up to ___ - ___ weeks for initial efficacy
5HT-1a
GAD
10-15, TID
3-4
BZDs
- ___ -term use is not recommended - dependence/tolerance
- acute withdrawal of BZD may lead to ___ that can be life-threatening
- warning for the use of BZD with other CNS depressants - specific warnings for co-prescribing with opioids
long
seizures
BZDs
no active metabolite (4)
- less likely to accumulate
- not as high as a ___ risk
long acting active metabolite (3)
- may lead to ___ and ___ risk, especially in elderly
SE
- sedation
- paradoxical excitement
- swallowing difficulties
- impairment of memory/recall
- psychomotor impairment
d/c requires slow __ over ___ to ___
- depending how long patient has been on BZD and their tolerance
Beer’s criteria - in elderly prefer (3) (LOT)
- alprazolam, loreazepam, clonazepam, oxazepam
- fall
- diazepam, clorazepate, chlordiazepoxide
- hangover, fall
- taper, weeks, months
lorazepam, oxazepam, temazepam
hydroxyzine
pamoate: FDA- approved for treatment for ___
- most commonly used ___ for anxiety or insomnia instead if BZD
- sedation and ___ SE are prominennt, QTc prolongation
- avoid use in the ___ ( ___ effects and ___ risk)
- 5HT2A antagonist and H1 receptor antagonists
GAD
- prn
- anticholinergic
- elderly, anticholinergic, fall
propranolol
decrease physiological symptoms of acute anxiety
- tachycardia, sweating, flushing
usefil for ___ and situationaly anxiety in prn doses
low doses - 10-20 mg 2-3x daily or LA dosage form
evaluate for asthma/CV conditions
natural
kava
st johns wort
passionflower
valerian
chamomile
gabapentinoids and quetiapine
may be considered in a patient with ___ disorder wo has anxirty symptoms or comorbid neuropathic pain
quetiapine is somrties prescribed for anxiety and sleep; evidence base is limited fo anxiety and sleep medicine does not endorse the use of quetiapine for insomnia
general drug therapy principles
___ and ___ are first line for all anxiety disorders
___ can also be used first line for GAD
BZD FDA-approved but ony use if necessary
atypical antipsychotics are not FDA spproved for anxiety, but clinical evidence suggests efficacy for treatment resistant OCD ( ___ and ___ )
SSRIs, SNRIs
buspirone
risperidone, aripiprazole
DSM-5 GAD
excessive anxiety/worry around life events, difficult to control, present for at least ___ months
symptoms include at least 3 of the following
- restlessness
- fatigued
- difficulty concentrating, mind going blank
- irritability
- muscle tension
- sleep disturbances
6
GAD treatment
- first line ___ - take 2-4 weeks for initial onset
- SNRIs - useful if patient also has ___
- BZD - ___ therapy to cover time until onset of SSRI/SNRI - MUST ___
- buspirone - good if dosed high enough and patient is aware how long it will take to work
- __ may be useful PRN; SE - anticholinergic and QTc prolongation
SSRI
pain
bridge
taper
hydroxyzine
social anxiety disorder
persistent fear about social and or performance situations in whihc the patient fears embarrassemnt or humiliation that is unreasonable
- specific situations may be ___ in a manner tha interferes with the patients normal routine
- durations of symptoms lasts at least ___ month
avoided
6
social anxiety disorder treatment
- ___ are first line ( ___ and ___ are FDA approved)
- __ - may be useful is failure ( ___ is FDA approved)
- ___ may be useful for non-generalized performance related SAD
- SSRI, paroxetine, sertraline
- SNRI, venlafaxine
- BBs
panic disorder
recurrent, ___ panic attacks
- abrupt surge of intense fear or discomfort
- at least 4 physical and psychological symptoms: sweating, alpitations, nausea, dixxiness, fear of losing control, going crazy, dying
at least one attack has been followed by one ___ or longer of at least one of the following
- persistent concern about additional attacks on their consequences
- significant maladaptive change in behavior releasred to attacks
unexpected
month
panic disorder treatment
- ___ are first line
- ____ - ___ is FDA approved
- ___ should not be considered first line maintenance unless inadequate response to ___ drugs
SSRI
SNRI, venlafaxine
BDZ, serotinergic